Evaluation of Amyloid Polypeptide Aggregation Inhibition and Disaggregation Activity of A-Type Procyanidins
Open Access
- 31 October 2021
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 14 (11) , 1118
Abstract
The number of people worldwide suffering from Alzheimer’s disease (AD) and type 2 diabetes (T2D) is on the rise. Amyloid polypeptides are thought to be associated with the onset of both diseases. Amyloid-β (Aβ) that aggregates in the brain and human islet amyloid polypeptide (hIAPP) that aggregates in the pancreas are considered cytotoxic and the cause of the development of AD and T2D, respectively. Thus, inhibiting amyloid polypeptide aggregation and disaggregation existing amyloid aggregates are promising approaches in the therapy and prevention against both diseases. Therefore, in this research, we evaluated the Aβ/hIAPP anti-aggregation and disaggregation activities of A-type procyanidins 1–7 and their substructures 8 and 9, by conducting structure–activity relationship studies and identified the active site. The thioflavin-T (Th-T) assay, which quantifies the degree of aggregation of amyloid polypeptides based on fluorescence intensity, and transmission electron microscopy (TEM), employed to directly observe amyloid polypeptides, were used to evaluate the activity. The results showed that catechol-containing compounds 1–6 exhibited Aβ/hIAPP anti-aggregation and disaggregation activities, while compound 7, without catechol, showed no activity. This suggests that the presence of catechol is important for both activities. Daily intake of foods containing A-type procyanidins may be effective in the prevention and treatment of both diseases.Keywords
Funding Information
- Japan Society for the Promotion of Science (JP24580156)
This publication has 42 references indexed in Scilit:
- Site-specific Inhibitory Mechanism for Amyloid β42 Aggregation by Catechol-type Flavonoids Targeting the Lys ResiduesJournal of Biological Chemistry, 2013
- Amyloid Structure: Conformational Diversity and ConsequencesAnnual Review of Biochemistry, 2011
- Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloidpeptide, insulin signaling, and neuronal functionMolecular BioSystems, 2011
- Covalent modification of proteins by green tea polyphenol (–)-epigallocatechin-3-gallate through autoxidationFree Radical Biology and Medicine, 2008
- Membrane interaction of islet amyloid polypeptideBiochimica et Biophysica Acta (BBA) - Biomembranes, 2007
- Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptideNature Reviews Molecular Cell Biology, 2007
- When quinones meet amino acids: chemical, physical and biological consequencesAmino Acids, 2006
- Formation and Stabilization Model of the 42-mer Aβ Radical: Implications for the Long-Lasting Oxidative Stress in Alzheimer's DiseaseJournal of the American Chemical Society, 2005
- Neuroprotective effects of resveratrol against β‐amyloid‐induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase CBritish Journal of Pharmacology, 2004
- Neurotoxicity and Physicochemical Properties of Aβ Mutant Peptides from Cerebral Amyloid AngiopathyJournal of Biological Chemistry, 2003